Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Q32 Bio
QTTB
$490M
| $211K | ﹤0.01% |
10,000
-6,617
| -40% | -$135K |
|
3077
Global X US Infrastructure Development ETF
PAVE
$15.1B
| $210K | ﹤0.01% |
6,900
-27,000
| -80% | -$852K |
|
|
SOHO
3078
DELISTED
Sotherly Hotels
SOHO
| $209K | ﹤0.01% |
123,712
+2,836
| +2% | +$5.68K |
|
3079
HF Foods Group
HFFG
$78.1M
| $208K | ﹤0.01% |
52,500
+9,600
| +22% | +$45.7K |
|
3080
JPMorgan US Quality Factor ETF
JQUA
$8.43B
| $208K | ﹤0.01% |
4,800
-14,000
| -74% | -$625K |
|
3081
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.82B
| $208K | ﹤0.01% |
+3,200
| New | +$220K |
|
|
AHG
3082
Akso Health Group
AHG
$1.25B
| $207K | ﹤0.01% |
199,398
-15,000
| -7% | -$8.6K |
|
|
TOUR
3083
Tuniu
TOUR
$56.5M
| $207K | ﹤0.01% |
17,233
-380
| -2% | -$5.28K |
|
3084
Femasys
FEMY
$9.09M
| $206K | ﹤0.01% |
3,456
+2,881
| +501% | +$30.1K |
|
3085
Auburn National Bancorp
AUBN
$91.7M
| $205K | ﹤0.01% |
9,541
-600
| -6% | -$13.1K |
|
3086
BGSF Inc
BGSF
$60.4M
| $205K | ﹤0.01% |
21,300
-9,638
| -31% | -$94.8K |
|
3087
Lisata Therapeutics
LSTA
$10.2M
| $205K | ﹤0.01% |
95,722
+2,400
| +3% | +$6.67K |
|
3088
VanEck Agribusiness ETF
MOO
$971M
| $205K | ﹤0.01% |
2,600
-2,639
| -50% | -$220K |
|
|
KE
3089
Kimball Electronics
KE
$644M
| $203K | ﹤0.01% |
7,425
-15,400
| -67% | -$440K |
|
|
ESPR
3090
DELISTED
Esperion Therapeutics
ESPR
| $202K | ﹤0.01% |
206,156
+91,856
| +80% | +$133K |
|
|
WKME
3091
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $202K | ﹤0.01% |
21,300
+1,400
| +7% | +$12.6K |
|
|
GOCO
3092
DELISTED
GoHealth
GOCO
| $201K | ﹤0.01% |
13,872
-2,000
| -13% | -$34.4K |
|
3093
The Beachbody Company
BODI
$79.2M
| $201K | ﹤0.01% |
13,618
+2,252
| +20% | +$45.2K |
|
3094
SIFCO Industries
SIF
$169M
| $200K | ﹤0.01% |
54,534
-9,900
| -15% | -$27K |
|
3095
Mueller Water Products
MWA
$4.13B
| $198K | ﹤0.01% |
+15,600
| New | +$225K |
|
3096
Ranpak Holdings
PACK
$472M
| $197K | ﹤0.01% |
+36,300
| New | +$199K |
|
3097
Recon Technology
RCON
$5.76M
| $196K | ﹤0.01% |
35,206
-17,383
| -33% | -$113K |
|
3098
Relmada Therapeutics
RLMD
$571M
| $196K | ﹤0.01% |
65,275
-67,497
| -51% | -$200K |
|
|
LYRA
3099
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $195K | ﹤0.01% |
996
-424
| -30% | -$75.8K |
|
3100
CuriosityStream
CURI
$155M
| $194K | ﹤0.01% |
272,900
+12,100
| +5% | +$10.6K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.